D
David E. Newby
Researcher at University of Edinburgh
Publications - 902
Citations - 45577
David E. Newby is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 98, co-authored 805 publications receiving 35865 citations. Previous affiliations of David E. Newby include NHS Lothian & Queen's University.
Papers
More filters
Journal ArticleDOI
Translocation and accumulation of inhaled gold nanoparticles in atherosclerotic plaque
Jeremy P. Langrish,Mark R. Miller,Jennifer Raftis,Ken Donaldson,Flemming R. Cassee,David E. Newby,Rodger Duffin,Nicholas L. Mills +7 more
TL;DR: Using complementary clinical and experimental studies, the possibility of particle translocation, and the fate of inhaled nanoparticles can translocate into the circulation are addressed.
Journal ArticleDOI
Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation.
Colin Stirrat,Shirjel Alam,Tom MacGillivray,Calum Gray,Marc R. Dweck,Victor Jones,William Wallace,John R. Payne,Sanjay K Prasad,Roy S Gardner,Mark C. Petrie,Mark C. Petrie,Saeed Mirsadraee,Peter Henriksen,David E. Newby,Scott Semple +15 more
TL;DR: In this paper, the superparamagnetic particles of iron oxide (USPIO)-enhanced MRI can detect cellular inflammation within tissues and may help non-invasively identify cardiac transplant rejection.
Journal ArticleDOI
Response to the Letter Regarding Article, “Previous Coronary Stent Implantation and Cardiac Events in Patients Undergoing Noncardiac Surgery”
Nicholas L. Cruden,Scott A Harding,Andrew D. Flapan,Cat Graham,Sarah H. Wild,Rachel Slack,Jill P. Pell,David E. Newby +7 more
TL;DR: To the Editor: Dr Lozano and colleagues highlight 2 important points that were not directly examined in the study, first, premature discontinuation of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery should be avoided, and second, careful consideration should be given to the use of aspirin and clopidogrel in these patients.
Journal ArticleDOI
Sensitive Troponin I Assay in Patients With Suspected Acute Coronary Syndrome—Reply
Journal ArticleDOI
High-sensitivity cardiac troponin and the classification of myocardial infarction
Andrew R. Chapman,Anoop S V Shah,Atul Anand,Philip D Adamson,Dennis Sandeman,Amy V. Ferry,Fiona E. Strachan,David E. Newby,Nicholas L. Mills +8 more
TL;DR: Whether more sensitive cardiac troponin assays can help to differentiate between subtypes is uncertain, but guidelines recommend classification of myocardial infarction due to plaque rupture or myocardIAL oxygen supply-demand mismatch.